Children with suspected or confirmed pulmonary TB or tuberculosis peripheral
lymphadenitis and/or children with extensive pulmonary disease, living in
settings where the prevalence of HIV is high and/or the prevalence of isoniazid
resistance is high1 should be treated with a four-drug regimen (HRZE) for
2 months followed by a two-drug regimen (HR) for 4 months at the dosages
specified in Recommendation 8